AMT-101

DB18555InvestigationalProtein Based Therapies

AMT-101 is a recombinant human interleukin-10 fusion protein.

Mechanism: Pharmacologically active on Interleukin-10 receptor subunit beta and Interleukin-10 receptor subunit alpha
Curator reviewed
Also known as: Recombinant human interleukin-10 fusion protein
Code names: AMT-101

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with AMT-101, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.